Freyer, Gilles <br/><br/>
Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Oct 2015 
 - 236 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-015-0682-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Attitude of Health Personnel<br/>Febrile Neutropenia--etiology<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Guideline Adherence--statistics & numerical data<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Physicians<br/>Risk Assessment--methods<br/>Risk Factors